Adding risk-enhancing factors improves 10-year ASCVD risk stratification in Chinese adults

FHS
June 27, 2023
3:02 am

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This study aimed to examine whether integrating risk-enhancing factors into the Chinese Society of Cardiology-recommended clinical risk assessment tool (i.e., the CSC model) for atherosclerotic cardiovascular disease (ASCVD) might improve 10-year ASCVD risk stratification in Chinese adults.

What health policies could hitch a ride on a spending bill?

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive

November 14, 2023

Development of lymphoma following CAR-T cell therapy

Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes.

February 22, 2025

J&J, Abbott and Intuitive start medtech earnings season

Second quarter earnings season starts this week, with Johnson & Johnson, Abbott and Intuitive Surgical set to report results that will provide pointers to the

July 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.